GETTING BIOTECH VENTURE CAPITAL INTO HOUSTON By Graham Randall, PhD When it comes to transforming Houston’s promising biotechnology into marketable products, the number and size of venture capital deals has been the hardest metric to improve. The typical VC investor looks for companies with strategic business plans driven by strong management teams. And there’s the […]Read More
Tags : investor
